4 comments

[ 2.9 ms ] story [ 18.9 ms ] thread
To be clear, there are tons and tons of cannabinoids that have been identified (see here: https://en.wikipedia.org/wiki/Synthetic_cannabinoids and here: https://en.wikipedia.org/wiki/Endocannabinoid_system and here: https://en.wikipedia.org/wiki/List_of_designer_drugs#Synthet...). What's particularly interesting about these is that they're phytocannabinoids, meaning that they're present in (at least some) cannabis and can help explain why folks don't respond to pure THC in the same way they respond to cannabis. The article mentions this a few times, but sadly it doesn't delve too deeply into what the parts of the cannabis effect profile might belong to THCP.

These aren't the first non-THC, non-CBD phytocannabinoids identified, here are the others currently known: https://en.wikipedia.org/wiki/Cannabinoid#Cannabis-derived_c...

It would be interesting to see what levels of THCP (and CBDP) are in commercial cannabis. And they didn't do the in vivo work with CBDP, which may be more tolerable to medical users since we try to avoid intoxicating compounds in medicine... yet we still have many pharmaceuticals that can get you high (e.g. opioids).

I am sure (I hope) we will see follow up studies with a variety of in vivo work.

I'd like to see more research on already known cannabinoids. From what I've read, the effects of CBD on its own are pretty limited; most of its strength lies in "entourage effects" when combined with THC. The same seems true of CBG and CBC, though (possibly) to a smaller degree. I'd rather not have to take THC to get the others' analgesic, anti-inflammatory, or anti-viral effects. Research oriented toward THC alternatives or additives that minimize its psychoactive effects while still unlocking CB[CDG]'s effects would be great. Anybody know of any?
Totally agree. I honestly think the research is way too limited, but the entourage effect looks promising. But you are right, when we talk about the entourage effect we usually only think about THC and CBD.

Not sure if you have seen these reviews (below), but they might be a good place to reference from. Ethan Russo seems to be the major authority on the subject. Although he is associated with GW pharmaceuticals, the producers of Epidiolex (CBD) for seizures.

https://www.researchgate.net/publication/317354478_Cannabis_...

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334252/